Canada Research Roundup: Aptose Biosciences, Canadian National Railway, TFI International

Flower One Holdings

22/09/2020 13:29

Sept 22 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Aptose Biosciences, Canadian National Railway and TFI
International, on Tuesday. 
    
    HIGHLIGHTS    
     * Aptose Biosciences Inc  APS.TO : Alliance Global Partners starts with buy rating
     * Canadian National Railway Co  CNR.TO : BMO raises target price to C$152 from C$140
     * TFI International Inc  TFII.TO : BMO raises target price to C$66 from C$62
        
Following is a summary of research actions on Canadian companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
    
     * Amex Exploration Inc  AMX.V : PI Financial raises target price to C$4.35 from C$4
     * Aptose Biosciences Inc  APS.TO : Alliance Global Partners starts with buy rating
     * Aptose Biosciences Inc  APS.TO : Alliance Global Partners starts with $12 target price
     * Canadian National Railway Co  CNR.TO : BMO raises target price to C$152 from C$140
     * Flower One Holdings  FONE.CD : Canaccord Genuity resumes coverage with speculative buy rating
     * Flower One Holdings  FONE.CD : Canaccord Genuity resumes coverage with C$0.50 PT 
     * Maverix Metals Inc  MMX.TO : PI Financial raises price target to C$9 from C$8.50
     * TFI International Inc  TFII.TO : BMO raises target price to C$66 from C$62
        

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))